SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe
The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

by Mary Durlak,University at BuffaloPost-operative panoramic X-ray; fixed implant-supported restoration. Credit: University at BuffaloIf you're a health care provider treating people with ty

The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

by Mary Durlak,University at BuffaloPost-operative panoramic X-ray; fixed implant-supported restoration. Credit: University at BuffaloIf you're a health care provider treating people with ty
Large-scale study reveals new genetic details of diabetes

Large-scale study reveals new genetic details of diabetes

by Wynne Parry,Cornell UniversityGraphical Abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/jNaNet.2023.09.013In experiments of unprecedented scale, investigators at Weill Cornel

Large-scale study reveals new genetic details of diabetes

by Wynne Parry,Cornell UniversityGraphical Abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/jNaNet.2023.09.013In experiments of unprecedented scale, investigators at Weill Cornel
Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis

Safer mass production of endocrine cells for stem cell-derived therapy for diabetes

Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis
cfDNA sequencing enhances non-invasive early detection of gestational diabetes

cfDNA sequencing enhances non-invasive early detection of gestational diabetes

by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample

cfDNA sequencing enhances non-invasive early detection of gestational diabetes

by BGI GenomicsClinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample
How does type 1 diabetes alter muscle structure and blood supply?

How does type 1 diabetes alter muscle structure and blood supply?

by Association of Basic Medical Sciences of FBIHExpression of myosin heavy chain isoforms 1 (A, E), 2a (B, F), 2x/d (C, G), and 2b (D, H) in successive cross-sections of gluteus maximusmuscle of

How does type 1 diabetes alter muscle structure and blood supply?

by Association of Basic Medical Sciences of FBIHExpression of myosin heavy chain isoforms 1 (A, E), 2a (B, F), 2x/d (C, G), and 2b (D, H) in successive cross-sections of gluteus maximusmuscle of
Researchers identify new mechanism that could improve the efficiency of diabetes treatments

Researchers identify new mechanism that could improve the efficiency of diabetes treatments

by University of BarcelonaProposed mechanistic model for the hepatic effects of Gdf15 deficiency on fibrosis, gluconeogenesis and fatty liver via the TGF-β1-SMAD3 pathway. Credit:Metabolism

Researchers identify new mechanism that could improve the efficiency of diabetes treatments

by University of BarcelonaProposed mechanistic model for the hepatic effects of Gdf15 deficiency on fibrosis, gluconeogenesis and fatty liver via the TGF-β1-SMAD3 pathway. Credit:Metabolism
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle
Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

by Joslin Diabetes CenterIn vivo AAV8-mediated overexpression of Mettl3 in NOD mouse β-cells delays T1D progression. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01368-0A

Shifting focus: Investigators describe changes to pancreatic β cells at onset of type 1 diabetes

by Joslin Diabetes CenterIn vivo AAV8-mediated overexpression of Mettl3 in NOD mouse β-cells delays T1D progression. Credit:Nature Cell Biology(2024). DOI: 10.1038/s41556-024-01368-0A
Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

by Verena Schulz,Helmholtz Association of German Research CentresCentral inceptor immunoreactivity is restricted to neurons, including those regulating energy and glucose metabolism. Credit:&nbs

Insulin-inhibitory receptor research offers hope for type 2 diabetes therapy

by Verena Schulz,Helmholtz Association of German Research CentresCentral inceptor immunoreactivity is restricted to neurons, including those regulating energy and glucose metabolism. Credit:&nbs